Cargando…
Comparison between a new assay system, Elecsys(®) Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional study
The sensitivity and specificity of a new automated electrochemiluminescence immunoassay system, Elecsys(®) Anti-p53 (Elecsys), were compared with that of the conventional serum anti-p53 antibody (s-p53-Ab) enzyme-linked immunosorbent assay kit [MESACUP anti-p53 test (MESACUP)]. Elecsys and MESACUP w...
Autores principales: | Suzuki, Takashi, Oshima, Yoko, Shiratori, Fumiaki, Nanami, Tatsuki, Yajima, Satoshi, Sumazaki, Makoto, Ushigome, Mitsunori, Sugita, Hironobu, Eberl, Magdalena, Ogata, Hideaki, Hayashida, Tetsu, Nakamura, Seigo, Nakagawa, Tsuyoshi, Shimada, Hideaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264320/ https://www.ncbi.nlm.nih.gov/pubmed/35832468 http://dx.doi.org/10.3892/mco.2022.2563 |
Ejemplares similares
-
The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma
por: Ito, Masaaki, et al.
Publicado: (2023) -
High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer
por: Ito, Masaaki, et al.
Publicado: (2019) -
Prognostic impact of p53 and/or NY‐ESO‐1 autoantibody induction in patients with gastroenterological cancers
por: Hoshino, Isamu, et al.
Publicado: (2020) -
Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer
por: Ito, Masaaki, et al.
Publicado: (2021) -
Preoperative Low Serum Calcium Levels Predict Poor Prognosis for Patients with Esophageal Cancer
por: Shiratori, Fumiaki, et al.
Publicado: (2021)